SRC
Sage Rhino Capital’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $254K | Buy |
6,612
+225
| +4% | +$8.64K | 0.05% | 199 |
|
|
2025
Q1 | $247K | Buy |
6,387
+156
| +3% | +$6.04K | 0.06% | 196 |
|
|
2024
Q4 | $211K | Buy |
6,231
+46
| +0.7% | +$1.56K | 0.05% | 234 |
|
|
2024
Q3 | $253K | Buy |
6,185
+109
| +2% | +$4.46K | 0.06% | 199 |
|
|
2024
Q2 | $234K | Sell |
6,076
-444
| -7% | -$17.1K | 0.06% | 197 |
|
|
2024
Q1 | $280K | Buy |
6,520
+178
| +3% | +$7.63K | 0.07% | 173 |
|
|
2023
Q4 | $235K | Sell |
6,342
-238
| -4% | -$8.82K | 0.06% | 184 |
|
|
2023
Q3 | $239K | Buy |
+6,580
| New | +$239K | 0.07% | 180 |
|
|
2022
Q3 | – | Sell |
-7,919
| Closed | -$345K | – | 197 |
|
|
2022
Q2 | $345K | Buy |
7,919
+189
| +2% | +$8.23K | 0.13% | 130 |
|
|
2022
Q1 | $337K | Buy |
7,730
+408
| +6% | +$17.8K | 0.1% | 154 |
|
|
2021
Q4 | $323K | Buy |
7,322
+985
| +16% | +$43.5K | 0.09% | 155 |
|
|
2021
Q3 | $242K | Buy |
6,337
+454
| +8% | +$17.3K | 0.07% | 169 |
|
|
2021
Q2 | $234K | Buy |
+5,883
| New | +$234K | 0.07% | 172 |
|
|
2020
Q4 | – | Sell |
-5,693
| Closed | -$214K | – | 181 |
|
|
2020
Q3 | $214K | Buy |
5,693
+566
| +11% | +$21.3K | 0.1% | 142 |
|
|
2020
Q2 | $209K | Buy |
+5,127
| New | +$209K | 0.11% | 144 |
|
|
2020
Q1 | – | Sell |
-5,130
| Closed | -$240K | – | 151 |
|
|
2019
Q4 | $240K | Buy |
5,130
+336
| +7% | +$15.7K | 0.14% | 126 |
|
|
2019
Q3 | $205K | Buy |
+4,794
| New | +$205K | 0.13% | 131 |
|